Results 281 to 290 of about 365,351 (311)

Renin-angiotensin system and cardiovascular risk

Lancet, The, 2007
Roland E Schmieder, Markus Peter Schlaich, Markus Schlaich   +2 more
exaly  

Angiotensin II

2009
M.J. McKinley, B.J. Oldfield
openaire   +1 more source

Key fibrogenic mediators: old players. Renin–angiotensin system

Kidney International Supplements, 2014
Giuseppe Remuzzi, Ariela Benigni
exaly  

Angiotensin II Receptor Pharmacology

1994
K K, Griendling, B, Lassègue, T J, Murphy, R W, Alexander   +3 more
openaire   +2 more sources

Angiotensin II analogs. 11. Des-aspartyl-angiotensin II

Journal of Medicinal Chemistry, 1974
Eugene C. Jorgensen, Ilona C. Kiraly-Olah, Thomas C. Lee, Graham C. Windridge   +3 more
openaire   +1 more source

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

Lancet, The, 2003
Jan Östergren, Karl Swedberg, Christopher B Granger   +2 more
exaly  

Angiotensin II/Angiotensin-(1–7)

2013
Patricia E. Gallagher, Alison L. Arter, Bhavani Krishnan, Maria A. Garcia-Espinosa, E. Ann Tallant   +4 more
openaire   +1 more source

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

Lancet, The, 2003
Christopher B Granger, Salim Yusuf, Jan Östergren   +2 more
exaly  

Angiotensin II

1994
openaire   +1 more source

Angiotensin II

2007
openaire   +1 more source